Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model

Nature Medicine

Volumn 10, Issue 11, 2004, Pages 1257-1260

  Uhrbom, Lene ^a,b   Nerio, Edward ^b   Holland, Eric C ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC ENGINEERING; GLIOMA; HISTOPATHOLOGY; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, TRANSGENIC; OLIGODENDROGLIOMA; PHTHALAZINES; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); PROTEIN KINASES; PYRIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 9144251024     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1120     Document Type: Article

References (19)

1. Sherr, C.J. & McCormick, F. The RB and p53 pathways in cancer. Cancer Cell 2, 103-112 (2002).
2. Johnson, D.G., Ohtani, K. & Nevins, J.R. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8, 1514-1525 (1994).
3. Parr, M.J. et al. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med. 3, 1145-1149 (1997).
4. Contag, C.H. et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66, 523-531 (1997).
5. Gelovani Tjuvajev, J. & Blasberg, R.G. In vivo imaging of molecular-genetic targets for cancer therapy. Cancer Cell 3, 327-332 (2003).
6. Massoud, T.F. & Gambhir, S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003).
7. Choy, G. et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35, 1022-1030 (2003).
8. Contag, P.R., Olomu, I.N., Stevenson, D.K. & Contag, C.H. Bioluminescent indicators in living mammals. Nat. Med. 4, 245-247 (1998).
9. Holland, E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2, 120-129 (2001).
10. Dai, C. et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15, 1913-1925 (2001).
11. Shih, A. et al. Dose dependent effects of PDGF-B on glial tumorigenesis. Cancer Res. (in press).
12. +/- mice. Proc. Natl. Acad. Sci. USA 98, 10320-10325 (2001).
13. Burgos, J.S. et al. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques 34, 1184-1188 (2003).
14. Rehemtulla, A. et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2, 491-495 (2000).
15. Rehemtulla, A. et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol. Imaging 1, 43-55 (2002).
16. Shah, K., Tang, Y., Breakefield, X. & Weissleder, R. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22, 6865-6872 (2003).
17. Dai, C. et al. The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct interchangable signaling formats. Neoplasia (in the press).
18. Garami, A. et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457-1466 (2003).
19. Rajasekhar, V.K. et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12, 889-901 (2003).